Free Case Evaluation
Connect
With Us

Author Archives: Jane Akre

Is Huskey Pelvic Mesh Case Going to the Supremes?

By Mesh Medical Device Newsdesk |

Mesh Medical Device News Desk, June 7, 2017 ~ The  pelvic mesh case of Huskey v. Ethicon has been in the courts since 2012. After she won a defective product case before a jury in 2014 and was awarded $3.27 million, J&J appealed and lost. Now Ethicon/ J&J wants the U.S. Supreme Court to [continue reading…]

Talcum Powder Trials Involving Three Plaintiffs Today in St. Louis

By Mesh Medical Device Newsdesk |

Mesh Medical Device News Desk, June 5, 2017 ~ The first trial involving multiple plaintiffs over J&J’s talcum powder and its link to ovarian cancer begins today in a St. Louis courtroom.   J&J is back in a St. Louis courtroom today, reports DrugWatch, facing three plaintiffs defending itself against charges that long-term use [continue reading…]

June Welcome to Mesh News Desk

By Mesh Medical Device Newsdesk |

The summer is almost upon us and pelvic mesh trials have been heating up in Philadelphia after a very long lull. Recently there have been $12.5, $13.5, $20 million and $2.16 million jury awards of compensation and nearly $35 million in punitive damages all leveled against J&J. After attending a shareholders meeting where “sustainability” [continue reading…]

Beltz v. Ethicon Jury Form in her Pelvic Mesh Trial

By Mesh Medical Device Newsdesk |

Mesh Medical Device News Desk, June 1, 2017 ~ The jury form in the Sharon Beltz v. Ethicon case shows mixed success in this latest pelvic mesh trial. Beltz v. Ethicon Jury Verdict Form Entered into the court May 31, 2017,  is the form that was filled out by the 12 jurors in the [continue reading…]

Pelvic Mesh Trials Ahead

By Mesh Medical Device Newsdesk |

Mesh Medical Device News Desk, May 31, 2017 ~ So far this 2017, the litigation in transvaginal mesh cases filed around the country seems to be picking up steam. This after a long lull in proceedings. Judge Joseph Goodwin had hoped to have the massive Mass Tort in his West Virginia court wrapped up [continue reading…]

Inside the Beltz Pelvic Mesh Trial

By Mesh Medical Device Newsdesk |

Mesh Medical Device News Desk, May 27, 2017 ~ The $2.16 million verdict for Sharon Beltz brought to an end the fourth consecutive trial for mesh-injured Plaintiffs in this court.  The jury verdict came down Friday May 26th after a 12-day trial in the Philadelphia Court of Common Pleas. Beltz was awarded a compensatory [continue reading…]

Beltz Pelvic Mesh Case Yields $2.16 Mill Verdict for Plaintiff!

By Mesh Medical Device Newsdesk |

Mesh Medical Device News Desk, May 26, 2017~ The case of Sharon Beltz v. Ethicon began with jury selection May 8. The case concluded Friday afternoon after a 12-day trial with a $2.16 million dollar jury verdict for Ms. Beltz.  This becomes the fourth consecutive win for mesh-injured plaintiffs in the Philadelphia Court of [continue reading…]

J&J’ Deceptive Practices Brings $33 Mil Fine

By Mesh Medical Device Newsdesk |

Mesh Medical Device News Desk, May 25, 2017 ~ For years, the healthcare giant has faced scrutiny over the cleanliness of its plants that produce its over-the-counter products.   Now J&J must pay $33 million over its “deceptive practices.” Fierce Pharma breaks the story this afternoon (here) of the $33 million fine Johnson & [continue reading…]

Morcellator Activist, Victim Amy Reed Dies at 44

By Mesh Medical Device Newsdesk |

Mesh  Medical Device News Desk, May 25, 2017 ~ Drs. Amy Reed and Hooman Noorchashm put a public face on the failures of the U.S. Food and Drug Administration and how it regulates medical devices.  Amy Reed, the Philadelphia physician who put a public, tragic face on the outcome of unregulated medical devices has [continue reading…]

Senate Bill Restricts Gifts From Big Pharma

By Mesh Medical Device Newsdesk |

Mesh Medical Device News Desk, May 24, 2017 ~ A bill just passed the California state Senate that restricts Big Pharma gifts to medical professionals, with the goal of reducing conflicts of interest. SB 790 severely restricts pharmaceutical companies from providing consulting fees, entertainment, flights, speaking fees, all of which can make the recipient [continue reading…]

© 2016 - 2017 Mesh Newsdesk. All rights reserved.
This news website is designed by NextClient.com.